139 related articles for article (PubMed ID: 34542865)
1. Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany.
Chen J; Williams P; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot NC; Thun B; Blüher M
Diabetes Ther; 2021 Nov; 12(11):2939-2953. PubMed ID: 34542865
[TBL] [Abstract][Full Text] [Related]
2. An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
Chen J; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot N; Lara N; Garcia Alvarez L; Roset M
Postgrad Med; 2020 Nov; 132(8):727-736. PubMed ID: 33108957
[TBL] [Abstract][Full Text] [Related]
3. Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain.
Rubio de Santos M; Artime E; Duque N; Díaz-Cerezo S; Spaepen E; Carreño Á; Fernández A
Diabetes Ther; 2022 Jun; 13(6):1147-1160. PubMed ID: 35449431
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics of insulin lispro 200 units/mL users in real world setting in Germany.
Schloot NC; Perez-Nieves M; Sapin H; Kruppert S; Otto T; Corrigan SM; Piras de Oliveira C
Curr Med Res Opin; 2020 Oct; 36(10):1611-1617. PubMed ID: 32845743
[TBL] [Abstract][Full Text] [Related]
5. Behaviours, thoughts and perceptions around mealtime insulin usage and wastage among people with type 1 and type 2 diabetes mellitus: A cross-sectional survey study.
Van Brunt K; Pedersini R; Rooney J; Corrigan SM
Diabetes Res Clin Pract; 2017 Apr; 126():30-42. PubMed ID: 28189952
[TBL] [Abstract][Full Text] [Related]
6. Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.
Wang T; Conrad KA; van Brunt K; Rees TM
J Diabetes Sci Technol; 2016 Jul; 10(4):923-31. PubMed ID: 26920640
[TBL] [Abstract][Full Text] [Related]
7. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
Clark PE; Valentine V; Bodie JN; Sarwat S
Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
Haak T; Edelman S; Walter C; Lecointre B; Spollett G
Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].
Böhler S; Landgraf W; Schreiber SA
MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
[TBL] [Abstract][Full Text] [Related]
11. A comparison of glide force characteristics between 2 prefilled insulin lispro pens.
Rees TM; Lennartz AH; Ignaut DA
J Diabetes Sci Technol; 2015 Mar; 9(2):316-9. PubMed ID: 25591858
[TBL] [Abstract][Full Text] [Related]
12. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
[TBL] [Abstract][Full Text] [Related]
13. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens.
Ignaut DA; Opincar MR; Clark PE; Palaisa MK; Lenox SM
Curr Med Res Opin; 2009 Dec; 25(12):2829-33. PubMed ID: 19916727
[TBL] [Abstract][Full Text] [Related]
14. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
[TBL] [Abstract][Full Text] [Related]
15. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
[TBL] [Abstract][Full Text] [Related]
16. Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch.
Peyrot M; Dreon D; Zraick V; Cross B; Tan MH
Diabetes Ther; 2018 Feb; 9(1):297-307. PubMed ID: 29327220
[TBL] [Abstract][Full Text] [Related]
17. Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates.
van der Burg T
J Diabetes Sci Technol; 2011 Jan; 5(1):150-5. PubMed ID: 21303637
[TBL] [Abstract][Full Text] [Related]
18. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
[TBL] [Abstract][Full Text] [Related]
19. Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis.
Veronesi G; Poerio CS; Braus A; Destro M; Gilberti L; Meroni G; Davis EM; Bossi AC
Clin Diabetes Endocrinol; 2015; 1():15. PubMed ID: 28702233
[TBL] [Abstract][Full Text] [Related]
20. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes.
Wong M; Abdulnabi R; Carey MA; Fu H
Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
